19 May 2013
Keywords: gsk, prepandrix, approved, ec, first, european, pre-pandemic
Article | 26 May 2008
The European Commission has approved UK drug major GlaxoSmithKline's H5N1 adjuvanted vaccine, Prepandrix, making it the first company to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 May 2008
17 May 2013
© 2013 thepharmaletter.com